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THIS studywas undertaken to evaluate the monocyte func-
tion of uraemic non-responders to hepatitis B vaccina-
tion. Therefore, some parameters concerning antigen
processing by monocytes (Mo) as antigen presenting
cells (APC) were analysed. It was found that in uraemic
non-responders, (1) the internalization of HBsAg
by monocytes was significantly decreasjed---HBsAg
complexed with specific IgG or as immune complex iso-
lated from patients is better internalized compared with
free HBsAg; (2) during antigen presentation the expres-
sion of adhesion (ICAM-1) and accessory (HLA-DR/Ia)
molecules was significantly decreased in uraemic pa-
tients, especially in non-responders; and (3) impaired
internalization of HBsAg as well as a decrease in ICAM-1
and ItLA-DR/Ia expression, correlated well with the
blunted proliferation of CD4 T cells stimulated by
autologous monocytes induced by HBsAg.
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Introduction
After immunization with hepatitis B (HBV) vac-
cine, 95% of healthy individuals develop antibodies
against hepatitis B surface antigen (HBsAg). In con-
trast, only 60-70% of dialysis patients show a
seroconversion even after additional injections of the
vaccine. Various attempts have been made to en-
hance antibody production and to clarify the causes
of this lack of response. Recent studies have shown
that in uraemic non-responders to HBV vaccination,
T lymphocytes do not receive the monocyte-derived
signals that are essential for adequate antigen pres-
entation. In vitro, this defect can partially be count-
eracted by addition of monocytes from healthy
donors2-4 or simultaneous supplementation of IL-2,
IL-1, IL-6 and IFN-/.
1,5 In the present study we tested
the monocyte internalization (phagocytic) capacity
for HBsAg, as well as adhesion (ICAM-1/intercellular
adhesion molecule-I) and accessory molecule
(HLA-DR/Ia) expression on monocytes induced by
HBsAg. The parameters examined were correlated
with responsiveness to HBV vaccination in patients
undergoing intermittent haemodialysis (ESRD
patients).
Materials and Methods
Patients: This study was carried out according to the
Declaration of Helsinki, and the informed consent of
each patient was obtained. Thirty haemodialysis
patients (20 males, ten females) who had not pro-
duced antibodies after at least four injections of H-
B-Vax-D vaccine (U-NR, uraemic non-responders)
and ten uraemic haemodialysis patients who had
responded to the vaccine (U-R, uraemic responders;
anti-HBs antibody titre higher than 10 U/l) were
included in the study. Ten healthy volunteers who
had responded well to HBV vaccination (C-R, control
responder; anti-HBs antibody higher than 10 U/l)
and ten healthy blood donors (C-NR, control non-
responders; Institute of Transfusiology, University of
Cologne) not responding to vaccination were
selected as control groups for the trial. The mean age
of patients was 25.6 years (range 8-28 years), the
mean duration of haemodialysis was 3.1 years (range
1-6 years). The mean age of controls was 28.5 years
(range 21-35 years). None of these subjects had the
hepatitis B virus infection before introduction to the
vaccination schedule (HBsAg-negative, anti-HBc/IgG
and anti-HBc/IgM-negative).
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Vaccination: Subjects were vaccinated (Gen-H-B-
Vax-D; Merck Sharp & Dohme) in accordance with
the standard schedule for hepatitis B vaccination
(four doses of 40 t.tg given intramuscularly, deltoid or
quadriceps muscle) at 0, 1, 2 and 6 months. Non-
responsiveness was defined if the antibody titre after
vaccination reached less than 10 U/1 6-8 weeks
following the last booster injection.
Purification of monocytes and T cells: Heparinized
blood was drawn before the haemodialysis session,
after the longest interdialytic interval in order to
minimize a direct influence of the previous
haemodialysis procedure. Peripheral blood mono-
nuclear cells (PBMC) were obtained by density
gradient centrifugation using Ficoll-Paque
(Lymphoflot, Biotest Diagnostics).
Monocytes were prepared from PBMC by adher-
ence to glass Petri dishes. Cells at 2 x 106/ml were
incubated in a 1 ml volume for 2 h at 37C in fiat-
bottom 24-well culture plates (Nunclon, InterMed
Nunc, Denmark). Adherent cells consisting of about
95% pure monocytes as assessed by measurement of
CD14 molecule expression (flow cytometry), were
used as APC.
Non-adherent cells were removed by washing.
CD4 T cells were prepared from non-adherent cells
by using the E-rosetting technique with subsequent
passage over the nylon wool column (to deplete
residual B cells and monocytes). Then the CD4 T
cells were purified by negative selection by using a
panning technique to deplete contaminating Ia posi-
tive cells and CD8 cells. Flow cytometry analysis of
the resultant CD4 population showed that contami-
nation with residual B cells (CD19), monocytes
(CD14) and CD8 cells was less than 1%.
In order to exclude an influence of nonspecific
monocyte activation by adherence, all experiments
were performed simultaneously with monocytes
originating from uraemic patients and controls (non-
responders, responders).
Internalization activity ofmonocytes: Internalization
analysis of HBsAg by monocytes was based on the
technique used in the Phagotest (Orpegen, Med-
Molekularbiologische Forschungsanstalt GmbH,
D-6900 Heidelberg), where either free HBsAg or
immune complexes containing HBsAg were used
instead of opsonized FITC-conjugated E. coli. Label-
ling of protein molecules with FITC is based on the
phenomenon that some amino acids, mainly lysine,
can bind fluorochrome molecules (FITC).-11 The
following HBsAg preparation were used in our ex-
periments: (1) free HBsAg (ad or ay subtypes,
Biodesign-International); (2) HBsAg conjugated .in
vitro with specific IgG (anti-HBs, goat IgG, B124046,
Biodesign-International); affinity of anti-HBs to
HBsAg ranged between 2 x 106 and 9 x 107 tool/l;
12
and (3) specific immune complexes containing
HBsAg (Ic-HBsAg-IgG) isolated from sera of chil-
dren suffering from glomerulonephritis associated
with HBV infection. 13 Sera were fractionated by
means of a two-stage chromatography system with
Sephadex G-200 filtration followed by Sepharose 6B,
using calibrated columns. 14
A solution of fluorescein 5-isothiocyanate (FITC, 3
mg, isomer F7250, Sigma, C21HlNO28) in borate
buffer (pH 9.25, 100 ml) was used for labelling
HBsAg-containing proteins.
7,8 The ratio of the
fluorochrome molecule (F) conjugated to the protein
molecule (P, HBsAg preparation) (F/P ratio) was
estimated photometrically in the FITC-HBsAg solu-
tion. The absorbance at 495 nm and at 280 nm was
determined using double-distilled water as a blank.
The results were calculated according to Equation 1.
F 6.85 x E4 (1) P E0- 0.35 x E495
The internalization of the HBsAg-preparation conju-
gated with FITC was assayed using a flow cytometer
(FACScan; Becton-Dickinson) using the live gate,
similar to that in the Phagotest procedure. FITC
positive cells gated as monocyte clusters were pro-
portional to the monocyte number that had
phagocytosed HBsAg. Fluorescence intensity, how-
ever, was proportional to the number of internalized
HBsAg molecules.
Antigen presentingfunction of monocytes: The anti-
gen presenting function of monocytes (Mo) was
tested by preparing HBsAg-pulsed monocytes (P-Mo,
2 x 10 cells/ml), which were subsequently cultured
with autologous CD4 T cells (1 x 105/ml) for 6 days.
P-Mo were prepared by placing 1 x 106 cells/ml in
polysulphon tubes, irradiating (2 500 rad) the cells
and then incubating them with or without HBsAg, at
a concentration of 100 ng/ml, in complete medium
for 18 h. Irradiated monocytes incubated with HBsAg
internalize and digest this antigen which is re-ex-
pressed on the surface of the cell in association with
HLA class II (MHC) and is presented onto T cells
during 6-day culture. 3a5,16 These irradiated monocytes
are not able to transform by cell division during the
culture, but they are able to perform the function of
surface receptor expression and monokine synthesis;
T lymphocytes then respond to the altered surface of
monocytes by proliferating. Only free HBsAg
(Biodesign-International) was used for the in vitro
stimulation in order to avoid the nonspecific
monocyte activation of IgG contained in immune
complexes via its Fc receptor.
Proliferation assays: The proliferative response of
CD4/T cells stimulated by P-Mo was determined by
H-thymidine incorporation (0.5 Ci/well; Sp. Ac. 5
Ci/mmol; Radiochemical Centre, Amersham Co.,
Oakville, Ontario, Canada). Assays were performed
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in triplicate and the radioactivity was expressed as
the mean count per minute (cpm) with standard
deviation (S.D.). The results are given as a stimula-
tion index (SI), calculated as in Equation 2.
SI cpm of CD4 T cells + P-Mo(HBsAg)
cpm of CD4 T cells + Mo(w/oHBsAg) (2)
Flowy tometry: PBMC were fluorescence labelled
using, simultaneously, fluorescein (FITC)-conjugated
anti-ICAM-1 (CD54, Dianova), or anti-HLA-DR/1A
mAb and phycoerythrin (PE)-labelled anti-CD14
mAb (Becton-Dickinson). Analysis was performed
by flow cytometry (FACScan, Becton-Dickinson) in
double colour, direct fluorescence. The instrument
was calibrated with inert beads to which a known
number of fluorescein molecules were covalently
bound (Flow Cytometry Standards Corp., Research
Triangle Park, NC). 17 Data were analysed using Con-
sort-30 software (Becton-Dickinson). Receptor ex-
pression was presented as receptor density (RD) on
the cell surface, shown as the mean fluorescence
intensity (MFI) in arbitrary units. MFI was propor-
tional to the number of receptor binding sites on the
cell surface.
Statistical analysis: All data were analysed by using
Student’s paired t-test (Statgraphics software pack-
age). Non-parametric equivalents of this test
(Kruskal-Wallis and Wilcoxon matched-pair rank
sum test) were also performed to confirm the results.
The significance level was p < 0.05.
facilitation of internalization processes has to be
taken into account.
Expression of adhesion and accessory molecules
(ICAM-1; HLA-DR/Ia) on monocytes: The percentage
of positive cells with regard to the defined receptors
(ICAM-1; HLA-DR/Ia) revealed no significant differ-
ences compared with controls. The expression of
accessory and adhesion molecules was interpreted as
RD. On freshly isolated uraemic monocytes the den-
sity of ICAM-1 (CD54) and HLA-DR/Ia molecules was
not significantly decreased (p > 0.05) (Table 1).
Induction of monocytes for 18 h with HBsAg as a
soluble protein (Table 1) resulted in an increased
HLA-DR/Ia expression both on uraemic and control
monocytes. Simultaneously, the differences between
non-responders and responders in the ESRD patient
group were enhanced. ICAM-1 density was also
higher compared with that on freshly isolated
monocytes, but no differences between uraemic
patients and controls could be detected.
When monocytes were cultured with CD4 T
lymphocytes these cell-to-cell interactions resulted in
a further increase of HLA-DR/Ia and ICAM-1 expres-
sion on monocytes but their expression was lower in
uraemic non-responders (Table 1).
Proliferative response ofhelper-inducer (CD4+) T cells
induced by autologous monocytespresenting HBsAg:
The proliferative response of CD4 T cells induced by
monocytes presenting HBsAg was significantly de-
creased in ESRD patients (p < 0.05), especially in non-
responders (p < 0.001) (Fig. 2).
Results
Internalization activity ofmonocytes: Internalization
of the HBsAg preparation by monocytes was meas-
ured by assessing phagocytic activity, using flow
cytometry (Fig. 1). In ESRD patients the mean
number of particles containing HBsAg phagocytes by
monocytes was significantly decreased compared
with that in controls (p < 0.001). Moreover, the mean
value of internalized molecules containing HBsAg
was especially low in uraemic non-responders com-
paredwith the value in uraemic responders (p < 0.05)
and in controls (p < 0.001). There were no differ-
ences in phagocytic (internalization) activity be-
tween ad- and ay-subtypes of HBsAg. However, the
pure HBsAg preparation was much less internalized
in all groups of examined patients and controls than
was the HBsAg complexed with IgG; the best inter-
nalization was observed by using specific immune
complexes (IC-HBsAg-IgG) isolated from patients
suffering from HBV related glomerulonephritis. The
monocytes are additionally able to bind IC-
HBsAg-IgG by their receptors to the Fc fragment of
IgG, as well as to the Clq receptors. Hence, this
Discussion
Impaired response to HBV vaccination in ESRD
patients still remains a pivotal problem in the preven-
tion of HBV infection among the patients and hospi-
tal staff in dialysis units. 18-2 Therefore, the present
study was focused on some events which are asso-
ciated with antigen processing by monocytes as APC.
We found that in uraemic non-responders to HBV
vaccination the internalization of HBsAg by
monocytes was significantly decreased; HBsAg was
better internalized as the immune complex HBsAg-
IgG. In the presentation processes the expression
of adhesion molecules (ICAM-1) and accessory
molecules (HLA-DR/Ia) was significantly decreased,
especially in uraemic non-responders. Impaired
internalization of HBsAg, as well as a decrease in
ICAM-1 and HLA-DR/Ia expression, correlated well
with the blunted proliferation of CD4 T cells stimu-
lated by autologous monocytes induced by HBsAg.
The lack of response to HBV vaccination in ESRD
patients may not only be related to uraemic toxicity
or intermittent exposure to the haemodialysis envi-
ronment2,21 but also seems to depend on individual
predisposition, associated with HLA-configura-




























FIG. 1. Internalization capacity of monocytes according to different HBsAg preparations in ESRD patients and controls, in .groups of responders and non-
responders to hepatitis B vaccination. Experiments were performed with free HBsAg, HBsAg prepared in vitro as an immune complex with specific IgG
(HBsAg-lgG) and with immune complexes (IC) isolated from serum of patients suffering from glomerulonephritis associated with HBV infection
(IC-HBsAg-lgG). Internalization of HBsAg preparations conjugated with FITC was assessed by flow cytometry (FACScan, Becton-Dickinson). The live gate
(Consort-30 Software) was estimated on the monocyte cluster by simultaneously defined forward scatter (FSC) and side scatter (SSC) parameters. Internal
mean green fluorescence intensity (FLl-axis X) represents the mean number of internalized HBsAg-FITC molecules per cell. Relative cell number (%, axis-
Y) indicates the number of monocytes internalizing HBsAg-FITC. U, ESRD patient; C, control; NR, non-responder; R, responder.
tion. 5’6’22’23 Available data concerning the impaired
function of monocytes in ESRD patients are based
mainly on the fact that addition of monocytes iso-
lated from healthy donors or, alternatively IL-2, re-
stores the inhibited proliferation ofT cells in uraemic
non-responders. 24-27 Unfortunately, the exact mecha-
nism involved in the process of antigen presentation
and recognition has not yet been resolved. Studies
performed in vitro have revealed a defect of IL-2
secreted by activated T cells,28,29 while a higher IL-2
receptor expression has been observed in patients
not responding to HBV vaccination.21,3,1
The dysregulation at the level of the TCR/CD3
receptor complex in T cell-monocytes cooperation
might result in an inadequate expression of adhesion
molecules (e.g. ICAM-1) as well as accessory or co-
stimulatory molecules (e.g. HLA-DR/Ia; CD4). 17 a co-
stimulatory signal is essential for the induction of IL-
2 synthesis and T cell proliferation. This co-
stimulatory activity delivered by monocyte-T cell
interactions involves the expression of adhesion
molecule ligands (e.g. ICAM-1/LFA-1) as well as the
synthesis and release if IL-1 and IL-6.2,3 Moreover,
the preactivation state in uraemia characterized by a
high IL-2 receptor (IL-2R) expression and a high
density of LFA-1] and CD4 molecules on helper-
inducer T cells may be a consequence of impaired
monocyte co-stimulatory function. 1’21’’32-35 In our
experimental system, in which CD4 T cells stimu-
lated by autologous activated monocytes served as
APC, the decrease in CD4 T lymphocyte prolifera-
tion in uraemic non-responders not only resulted
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Table 1. ICAM-1 adhesion molecule expression and expression of HLA-DR/la accessory molecule
expression on monocytes"
Before culture
After 18 h After 6 days culture
induction with with autologous
HBsAg CD4 T cells
NR R NR R NR R
ICAM-1 _(R)_ __
ESRD patients 180 + 35 192 +/- 43 600 +/- 110 640 +/- 125 305 +/- 72 450 +/- 68
Controls 250 +/- 53 305 +/- 49 490 +/- 95 510 +/- 78 682 +/- 145 835 +/- 121
HLA-DR/la
ESRD patients 410 +/- 120 420 +/- 110 550 +/- 121 693 +/- 193 301 +/- 135 410 +/- 92
(R) (R) (R) @
Controls 432 +/- 93 441 +/- 105 833 +/- 190 945 +/- 114 995 +/- 232 1115 +/- 167
"Two-colour flow cytometry (Becton-Dickinson, FACScan) was performed by using monoclonal antibod-
ies anti-ICAM-1 and anti-HLA-DR conjugated with FITC and anti-CD14 labelled with PE. Analysis was
undertaken before and after the 6 day culture of helper-inducer T cells with autologous monocytes
presenting HBsAg. ICAM-1 and HLA-DR/la were also estimated on monocytes following induction with
HBsAg and directly before institution to the culture.
bMolecule expression is presented as their density (RD) on the cell surface and is given in arbitrary units
of mean fluorescence intensity (MFI). The MFI of background staining (Simultest control; IgG1-FITC and
IgG2-PE) ranged from 10 to 13 arbitrary units. Mean values +/- S.D. of 30 experiments are presented.
Differences between responders (R) and non-responders (NR) within the groups of ESRD patients or
controls.










FIG. 2. Proliferative response of helper-inducer (CD4) T cells induced by
monocytes presenting HBsAg. Data are expressed as stimulation index
(SI). U, uraemic patients; C, controls; NR, non-responders; R, responders.
Mean values S.D. of 30 experiments are presented.
from impaired IL-2 production, but also from
dysregulation in the synthesis of IL-1, IL-6, IL-4 and
IFN-7 (data not shown). These findings, associated
with a decreased number of IL-1 receptors and IL-6
receptors and a simultaneous increase in IL-2R ex-
pression on freshly isolated CD4 T cells, indicate
also that co-stimulation of IL-2-dependent T-cell
activation concerning IL-1 and IL-6 activity is im-
paired. 5,16,32 It is also possible that other factors pro-
duced by activated monocytes (e.g. transforming
growth factor-[, leukotrienes, prostaglandins-E, TNF-
00 may suppress antigen-induced T lymphocyte pro-
liferation.31,2,6
Using flow cytometry methods, quantitative deter-
mination of monocyte phagocytosis was possible.
Monocyte internalization of HBsAg-FITC, measured
as phagocytic activity, was significantly decreased in
ESRD patients, especially in non-responders. This
possibly leads to impaired transformation of this
antigen and inadequate presentation to T
lymphocytes. However, the use of HBsAg as an
immune complex with IgG, and especially as an
isolated IC-HBsAg-IgG, improved the blunted
monocyte function of antigen internalization, com-
pared with the free HBsAg. This tendency was ob-
served in all groups of patients examined. These
immune complexes also resulted in an improvement
of ICAM-1 and HLA-DR/Ia expression (data not
shown).
The mechanism of impaired phagocytosis and/or
internalization observed in uraemia is not well
known. However, some authors suggest disorders in
ATP content and resting levels of cytosolic calcium
(Cai) in leukocytes7-9 as well as the negative influ-
ence of parathormone on these events. The present
study was performed only with leukocytes without
separation of monocytes, as APC with regards to
HBsAg. Hence, similar disorders in the internaliza-
tion processes of uraemic monocytes affecting the
antigen signalling pathway should be considered.
Adequate antigen presentation and co-stimulatory
events are regulated by the TCR/CD3 receptor com-
plex and various cytokines (e.g.TNF-0q IFN-
7), 4’16’33’40’41 For instance, IFN-7 induces increased
expression of ICAM-1, which correlates well with
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enhanced antigen presentation by monocytes. Based
on our results in uraemic non-responders the im-
paired signalling could depend on low ICAM-1 and
HLA-DR expression. The decreased production of
IFN-3’ in ESRD patients, in particular in non-respond-
ers (data not shown), may result in blunted antigen
presentation of monocytes. It would also be impor-
tant to know whether the concentration of soluble
forms of ICAM-1 in serum and in culture supernatants
is changed in the examined group of uraemic pa-
tients and controls. Soluble ICAM-1 might regulate
the expression of its ligand (LFA-1) on CD4 T cells
as well as serving as a prognostic and diagnostic
marker of the inflammatory status of these pa-
tients.42,43
In conclusion, the parameters examined only par-
tially involve the phenomena concerning monocyte
antigen processing and presentation. Additional
events should be taken into account for further
investigations, e.g. intracellular processing of HBsAg
following its internalization into monocytes, and a
wider variety of adhesion and accessory molecules.
Thus, further analysis of the precise mechanisms
could lead to simultaneous administration of differ-
ent cytokines to improve the impaired response to
HBV vaccination in dialysis patients, by providing
the co-stimulatory signal.
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